Hepion Pharmaceuticals
HEPA
#10558
Rank
S$1.2 M
Marketcap
S$0.10
Share price
14.29%
Change (1 day)
-99.75%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -S$11.22 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$20.13 Million, an increase over its 2023 earnings that were of -S$63.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$11.22 Million-44.27%
2024 -S$20.13 Million-68.5%
2023 -S$63.89 Million9.74%
2022 -S$58.22 Million37.49%
2021 -S$42.35 Million61.27%
2020 -S$26.26 Million174.55%
2019 -S$9.57 Million-31.28%
2018 -S$13.92 Million
2016 -S$27.62 Million6.03%
2015 -S$26.05 Million265%
2014 -S$7.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 1,610.85%๐Ÿ‡บ๐Ÿ‡ธ USA